Efficacy of Tofacitinib in Treatment of Alopecia Universalis in Two Patients
June 2016
in “
Journal of the European Academy of Dermatology and Venereology
”
Studysummary In this study, tofacitinib treatment was associated with significant hair regrowth in two patients with alopecia universalis over eight months, with minimal adverse effects reported.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on onlinelibrary.wiley.com →